Blue skies for pain plays

Specialty pain plays Pacira and Zogenics prepare for IPOs

Blue skies for pain plays

Specialty pharma Pacira Pharmaceuticals Inc. filed to raise up to $86.3 million in an IPO. The company (formerly Blue Acquisition Corp.) was formed when it acquired the injectable business of SkyePharma plc (LSE:SKP; SKYE) for

Read the full 390 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE